Resonetics’ Investment In Medibrane

Kirkland & Ellis represented Resonetics in an equity investment in Medibrane.

Resonetics first acquired a minority ownership in Medibrane as part of its November 2018 acquisition of STI Laser, also based in Israel. Medibrane designs, develops and manufactures customized polymeric coverings and coatings that are used with nitinol frames in interventional procedures for structural heart, interventional cardiology, neurovascular and other minimally invasive procedures.

The Kirkland team was led by transactional partners Sanford Perl (Picture) and Michael Weed.

Involved fees earner: Sanford Perl – Kirkland & Ellis; Michael Weed – Kirkland & Ellis;

Law Firms: Kirkland & Ellis;

Clients: Resonetics;

Author: Ambrogio Visconti